Bioservo Q4’21: Interesting Runway for Growth - Redeye

Redeye comments on the Q4 report from Bioservo. In total, a report without any surprises in our view. Sales are still low as expected, and costs are maintained at reasonable levels. We are making minor adjustments to our estimates as we roll over our DCF model. We reiterate our fair value range of SEK 10 to 28 per share with a Base case of SEK 18 per share.

Länk till analysen i sin helhet: https://www.redeye.se/research/833590/bioservo-q421-interesting-runway-for-growth?utm_source=finwire&utm_medium=RSS